I Sturm - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

I Sturm

Showing results (11-20 of 24) with videos related to

Pageof 3

Sort By:

International Journal of Cancer|May 15, 2001

Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinomaS Hermann, I Sturm, A Mrozek, et al.

Blood|July 27, 1999

Expression of the death gene Bik/Nbk promotes sensitivity to drug-induced apoptosis in corticosteroid-resistant T-cell lymphoma and prevents tumor growth in severe combined immunodeficient miceP T Daniel, K T Pun, S Ritschel, et al.

Advances in Experimental Medicine and Biology|February 23, 1999

Retroviral B7.1 gene transfer in cancer cells protects cytotoxic T cells from deletion by "veto" apoptosisP T Daniel, A Kroidl, S Cayeux, et al.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 1, 1996

Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipientI Sturm, B Watschinger, K Geissler, et al.

International Journal of Cancer|August 5, 2000

Impaired BAX protein expression in breast cancer: mutational analysis of the BAX and the p53 geneI Sturm, S Papadopoulos, T Hillebrand, et al.

Investigational New Drugs|July 12, 2015

Topotecan plus cyclophosphamide in adults with relapsed or refractory pediatric-type sarcoma: a retrospective analysis from the German Sarcoma Medical Oncology Group (AIO)Jörg Thomas Hartmann, R D Issels, K San Nicolo, et al.

Cell Death and Differentiation|April 30, 2003

Combined p53/Bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instabilityA Mrózek, H Petrowsky, I Sturm, et al.

Leukemia|June 1, 2002

Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemiaA G Bosanquet, I Sturm, T Wieder, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999

Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastasesI Sturm, C H Köhne, G Wolff, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001

Analysis of p53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: high BAX and p16(ink4a/CDKN2) identifies patients with good prognosisI Sturm, H Petrowsky, R Volz, et al.

Pageof 3

Search research articles

Showing results (11-20 of 24) with videos related to

Sort By:

Pageof 3

International Journal of Cancer|May 15, 2001

Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinomaS Hermann, I Sturm, A Mrozek, et al.

Blood|July 27, 1999

Advances in Experimental Medicine and Biology|February 23, 1999

Retroviral B7.1 gene transfer in cancer cells protects cytotoxic T cells from deletion by "veto" apoptosisP T Daniel, A Kroidl, S Cayeux, et al.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 1, 1996

Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipientI Sturm, B Watschinger, K Geissler, et al.

International Journal of Cancer|August 5, 2000

Impaired BAX protein expression in breast cancer: mutational analysis of the BAX and the p53 geneI Sturm, S Papadopoulos, T Hillebrand, et al.

Investigational New Drugs|July 12, 2015

Cell Death and Differentiation|April 30, 2003

Combined p53/Bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instabilityA Mrózek, H Petrowsky, I Sturm, et al.

Leukemia|June 1, 2002

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999

Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastasesI Sturm, C H Köhne, G Wolff, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001

Analysis of p53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: high BAX and p16(ink4a/CDKN2) identifies patients with good prognosisI Sturm, H Petrowsky, R Volz, et al.

Pageof 3